
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
Certara announced a partnership with Beijing–based Phase I Unit, Peking Union Medical College (PUMC) Hospital’s Clinical Pharmacology Research Center.
Certara announced a partnership with Beijing–based Phase I Unit, Peking Union Medical College (PUMC) Hospital’s Clinical Pharmacology Research Center. This partnership aims to help Chinese pharmaceutical companies improve their drug development processes.
Read the full release






